Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Akari Therapeutics Plc See All Filings	D	2025-10-24 08:45:14 UTC
Amount To Be Raised $6,250,000 Associated Brokers / Dealers Ladenburg Thalmann & Co. Inc. CIK Number 0001541157 Filed Document 0001493152-25-019187 Exclusions or Exemptions 506b Accepted Date 2025-10-24 08:45:14 UTC Type of Offering D Industry Other Health Care Principal Place of Business FLORIDA Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akari Therapeutics Plc See All Filings	D	2024-01-09 17:25:48 UTC
Amount To Be Raised $2,000,001 Associated Brokers / Dealers Paulson Investment Company LLC CIK Number 0001541157 Filed Document 0000911420-24-000004 Exclusions or Exemptions 506b Accepted Date 2024-01-09 17:25:48 UTC Type of Offering D Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Akari Therapeutics Plc See All Filings	D	2023-10-19 16:17:36 UTC
Amount To Be Raised $1,971,001 Associated Brokers / Dealers PAULSON INVESTMENT COMPANY LLC CIK Number 0001541157 Filed Document 0001567619-23-007516 Exclusions or Exemptions 506c Accepted Date 2023-10-19 16:17:36 UTC Type of Offering D Industry Other Health Care Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Akari Therapeutics Plc See All Filings	D	2022-09-27 16:16:30 UTC
Amount To Be Raised $12,835,000 Associated Brokers / Dealers A.G.P./Alliance Global Partners CIK Number 0001541157 Filed Document 0001104659-22-103309 Exclusions or Exemptions 506b Accepted Date 2022-09-27 16:16:30 UTC Type of Offering D Industry Biotechnology Principal Place of Business UNITED KINGDOM Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akari Therapeutics Plc See All Filings	D	2020-03-11 16:30:36 UTC
Amount To Be Raised $9,554,528 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001541157 Filed Document 0001104659-20-031954 Exclusions or Exemptions 506b Accepted Date 2020-03-11 16:30:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business UNITED KINGDOM Revenue or Assets Decline to Disclose Type of Security Equity
Akari Therapeutics Plc See All Filings	D	2019-07-12 16:32:19 UTC
Amount To Be Raised $4,499,945 Associated Brokers / Dealers Paulson Investment Company, LLC CIK Number 0001541157 Filed Document 0001144204-19-034585 Exclusions or Exemptions 506b Accepted Date 2019-07-12 16:32:19 UTC Type of Offering D Industry Biotechnology Principal Place of Business UNITED KINGDOM Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Akari Therapeutics Plc See All Filings	D	2015-09-28 00:00:00 UTC
Amount To Be Raised $75,000,000 Associated Brokers / Dealers MTS Securities, LLC and Citigroup Global Markets Inc. CIK Number 0001541157 Filed Document 0001541157-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-09-28 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business UNITED KINGDOM Revenue or Assets Decline to Disclose Type of Security Equity
Celsus Therapeutics Plc. See All Filings	D	2013-09-30 00:00:00 UTC
Amount To Be Raised $12,516,232 Associated Brokers / Dealers MTS Securities, LLC and Oppenheimer & Co. Inc. CIK Number 0001541157 Filed Document 0001541157-13-000002 Exclusions or Exemptions 506c Accepted Date 2013-09-30 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business UNITED KINGDOM Revenue or Assets $No Revenues Type of Security Equity